Sign inJoin waitlistJoin the waitlist

CK

Cassandra Key

Internal Medicine

Credentials: ·

History

Internal Medicine
2006–2009
Medical School
2002–2006

Research

Amycretin, a novel, unimolecular GLP-1 and amylin receptor agonist administered subcutaneously: results from a phase 1b/2a randomised controlled study
The Lancet · 2025 · 52 citations
Safety, tolerability, pharmacokinetics, and pharmacodynamics of the first-in-class GLP-1 and amylin receptor agonist, amycretin: a first-in-human, phase 1, double-blind,…
The Lancet · 2025 · Last of 10 authors
Phase 1 Studies to Assess Inhaled Seralutinib as a Perpetrator or a Victim of Drug-Drug Interactions in Healthy Participants
Clinical Pharmacology in Drug Development · 2025

Ania Jastreboff
1 paper · 1 as a resident
DR
Dennis Ruff
1 paper
ED
Emanuel Denoia
1 paper
TS
Taylor Sandison
1 paper